Double Blind, Placebo-controlled, Dose Finding, Prospective, Multicenter Clinical Trial for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Latest Information Update: 31 Jan 2022
At a glance
Most Recent Events
- 10 Nov 2021 Status changed from recruiting to completed.
- 12 Jun 2020 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 12 Jun 2020 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.